Google spinoff Isomorphic Labs is in a race to shake up the long, painful road to cancer-beating drugs

Isomorphic Labs, a Google DeepMind spinoff led by Demis Hassabis and Max Jaderberg, aims to accelerate drug discovery for cancer using AI. The London-based team is focused on transforming the traditionally slow and costly drug development process.